GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
GILD
Main Stock$141.95
Tradestie Score
63
Market Cap
$137.92B
P/E Ratio
21.6
Revenue Growth
0.0%
Analyst Upside
-3.7%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$341.88
|
$160.70B | 26.4 | 66 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$840.50
|
$46.96B | 36.2 | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$113.75
|
$24.57B | - | 59 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$179.89
|
$22.61B | 15.9 | 58 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$136.06
|
$13.59B | 32.1 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$41.36
|
$11.09B | 17.9 | 43 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$44.07
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$53.67
|
$10.04B | 27.7 | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$64.09
|
$9.33B | 133.8 | 57 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$71.71
|
$8.77B | 15.4 | 64 | Compare |
More GILD Analysis
Data updated: Jan 31, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry